Enterprise Value
0.00
Cash
123.6M
Avg Qtr Burn
N/A
Short % of Float
2.95%
Insider Ownership
6.64%
Institutional Own.
76.83%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CYT-0851 w/ capecitabine Details Cancer, Ovarian cancer | Failed Discontinued | |
CYT-0851 w/ gemcitabine Details Solid tumor/s, Cancer | Failed Discontinued |